Novel use of peptide compounds for treating essential tremor and other tremor syndromes

Details for Australian Patent Application No. 2005256468 (hide)

Owner UCB Pharma GmbH

Inventors Stohr, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2005256468

PCT Pub. Number WO2006/000397

Priority 60/582,084 24.06.04 US

Filing date 22 June 2005

Wipo publication date 5 January 2006

Acceptance publication date 9 December 2010

International Classifications

A61K 38/03 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in an undefined or only partially defined sequence

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/000397 Priority application(s): WO2006/000397

25 November 2010 Alteration of Name

  The name of the applicant has been altered to UCB Pharma GmbH

9 December 2010 Application Accepted

  Published as AU-B-2005256468

7 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005256470-Novel compounds

2005256442-Pyrimidine derivatives as 11beta-HSD1 inhibitors